Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT 1D agonist sumatriptan

By Stern L.   Zohar J.   Cohen R.   Sasson Y.  

European Neuropsychopharmacology, Vol. 8, Iss. 4, 1998-12 ,pp. : 325-328

Elsevier

Access to resources Recommend Favorite

[ 3 H]Sumatriptan binding sites in human brain: regional-dependent labelling of 5-HT 1D and 5-HT 1F receptors

By Pascual J.   Del Arco C.   Romon T.   Del Olmo E.   Pazos A.  

European Journal of Pharmacology, Vol. 295, Iss. 2, 1996-01 ,pp. : 271-274

Elsevier

Access to resources Recommend Favorite

Zolmitriptan (a 5-HT receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder

By Boshuisen M.L.   den Boer J.A.  

Psychopharmacology, Vol. 152, Iss. 1, 2000-09 ,pp. : 74-79

Springer Publishing Company

Access to resources Recommend Favorite

Advances in the pharmacotherapy of obsessive-compulsive disorder

By Bisserbe J.C.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 260-260

Elsevier

Access to resources Recommend Favorite

Pathogenetic mechanism of obsessive-compulsive disorder

By Kafka J.   Paacute lovaacute E.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 370-371

Elsevier

Access to resources Recommend Favorite